444 related articles for article (PubMed ID: 33435948)
1. Skin autofluorescence predicts new cardiovascular disease and mortality in people with type 2 diabetes.
Boersma HE; van Waateringe RP; van der Klauw MM; Graaff R; Paterson AD; Smit AJ; Wolffenbuttel BHR
BMC Endocr Disord; 2021 Jan; 21(1):14. PubMed ID: 33435948
[TBL] [Abstract][Full Text] [Related]
2. Skin autofluorescence predicts incident type 2 diabetes, cardiovascular disease and mortality in the general population.
van Waateringe RP; Fokkens BT; Slagter SN; van der Klauw MM; van Vliet-Ostaptchouk JV; Graaff R; Paterson AD; Smit AJ; Lutgers HL; Wolffenbuttel BHR
Diabetologia; 2019 Feb; 62(2):269-280. PubMed ID: 30460578
[TBL] [Abstract][Full Text] [Related]
3. Skin autofluorescence predicts major adverse cardiovascular events in patients with type 1 diabetes: a 7-year follow-up study.
Blanc-Bisson C; Velayoudom-Cephise FL; Cougnard-Gregoire A; Helmer C; Rajaobelina K; Delcourt C; Alexandre L; Blanco L; Mohammedi K; Monlun M; Rigalleau V
Cardiovasc Diabetol; 2018 Jun; 17(1):82. PubMed ID: 29884175
[TBL] [Abstract][Full Text] [Related]
4. Skin autofluorescence, arterial stiffness and Framingham risk score as predictors of clinical outcome in chronic kidney disease patients: a cohort study.
Mukai H; Svedberg O; Lindholm B; Dai L; Heimbürger O; Barany P; Anderstam B; Stenvinkel P; Qureshi AR
Nephrol Dial Transplant; 2019 Mar; 34(3):442-448. PubMed ID: 29378035
[TBL] [Abstract][Full Text] [Related]
5. Skin autofluorescence as tool for cardiovascular and diabetes risk prediction.
Smit AJ; van de Zande SC; Mulder DJ
Curr Opin Nephrol Hypertens; 2022 Nov; 31(6):522-526. PubMed ID: 36172853
[TBL] [Abstract][Full Text] [Related]
6. Associations of Serum Folate and Vitamin B12 Levels With Cardiovascular Disease Mortality Among Patients With Type 2 Diabetes.
Liu Y; Geng T; Wan Z; Lu Q; Zhang X; Qiu Z; Li L; Zhu K; Liu L; Pan A; Liu G
JAMA Netw Open; 2022 Jan; 5(1):e2146124. PubMed ID: 35099545
[TBL] [Abstract][Full Text] [Related]
7. Hemoglobin glycation index predicts cardiovascular disease in people with type 2 diabetes mellitus: A 10-year longitudinal cohort study.
Kim MK; Jeong JS; Yun JS; Kwon HS; Baek KH; Song KH; Ahn YB; Ko SH
J Diabetes Complications; 2018 Oct; 32(10):906-910. PubMed ID: 30121206
[TBL] [Abstract][Full Text] [Related]
8. Skin autofluorescence as proxy of tissue AGE accumulation is dissociated from SCORE cardiovascular risk score, and remains so after 3 years.
Tiessen AH; Jager W; ter Bogt NC; Beltman FW; van der Meer K; Broer J; Smit AJ
Clin Chem Lab Med; 2014 Jan; 52(1):121-7. PubMed ID: 23612547
[TBL] [Abstract][Full Text] [Related]
9. Risk Factor Control and Cardiovascular Event Risk in People With Type 2 Diabetes in Primary and Secondary Prevention Settings.
Wright AK; Suarez-Ortegon MF; Read SH; Kontopantelis E; Buchan I; Emsley R; Sattar N; Ashcroft DM; Wild SH; Rutter MK
Circulation; 2020 Nov; 142(20):1925-1936. PubMed ID: 33196309
[TBL] [Abstract][Full Text] [Related]
10. Nationwide cardiovascular risk categorization: applying the European Society of Cardiology guidelines to the Swedish National Diabetes Register.
Eliasson B; Ekelund J; Holmberg CN; Wolden ML; Matthiessen KS; James S
Eur J Prev Cardiol; 2023 May; 30(7):546-551. PubMed ID: 36567502
[TBL] [Abstract][Full Text] [Related]
11. Lifestyle and clinical determinants of skin autofluorescence in a population-based cohort study.
van Waateringe RP; Slagter SN; van der Klauw MM; van Vliet-Ostaptchouk JV; Graaff R; Paterson AD; Lutgers HL; Wolffenbuttel BH
Eur J Clin Invest; 2016 May; 46(5):481-90. PubMed ID: 27002914
[TBL] [Abstract][Full Text] [Related]
12. A non-invasive risk score including skin autofluorescence predicts diabetes risk in the general population.
Boersma HE; van der Klauw MM; Smit AJ; Wolffenbuttel BHR
Sci Rep; 2022 Dec; 12(1):21794. PubMed ID: 36526712
[TBL] [Abstract][Full Text] [Related]
13. Autofluorescence of Skin Advanced Glycation End Products: Marker of Metabolic Memory in Elderly Population.
Rajaobelina K; Cougnard-Gregoire A; Delcourt C; Gin H; Barberger-Gateau P; Rigalleau V
J Gerontol A Biol Sci Med Sci; 2015 Jul; 70(7):841-6. PubMed ID: 25589479
[TBL] [Abstract][Full Text] [Related]
14. Incremental risk of cardiovascular disease and/or chronic kidney disease for future ASCVD and mortality in patients with type 2 diabetes mellitus: ACCORD trial.
Branch M; German C; Bertoni A; Yeboah J
J Diabetes Complications; 2019 Jul; 33(7):468-472. PubMed ID: 31088728
[TBL] [Abstract][Full Text] [Related]
15. Advanced glycation end products (AGEs) estimated by skin autofluorescence are related with cardiovascular risk in renal transplant.
Calviño J; Cigarran S; Gonzalez-Tabares L; Menendez N; Latorre J; Cillero S; Millan B; Cobelo C; Sanjurjo-Amado A; Quispe J; Garcia-Enriquez A; Carrero JJ
PLoS One; 2018; 13(8):e0201118. PubMed ID: 30067789
[TBL] [Abstract][Full Text] [Related]
16. Sudomotor dysfunction independently predicts incident cardiovascular-renal events and all-cause death in type 2 diabetes: the Joint Asia Diabetes Evaluation register.
Lim LL; Fu AWC; Lau ESH; Ozaki R; Cheung KKT; Ma RCW; Luk AOY; Chan JCN; Kong APS
Nephrol Dial Transplant; 2019 Aug; 34(8):1320-1328. PubMed ID: 29939305
[TBL] [Abstract][Full Text] [Related]
17. Evaluation of skin autofluorescence as a surrogate of advanced glycation end products accumulation in children and adolescents with normal haemoglobin A1c values.
Jankowska M; Bobeff K; Baranowska-Jaźwiecka A; Mianowska M; Lubnauer A; Michalak A; Młynarski W; Szadkowska A; Mianowska B
Pediatr Endocrinol Diabetes Metab; 2020; 26(1):1-9. PubMed ID: 32418416
[TBL] [Abstract][Full Text] [Related]
18. HbA
Metcalf PA; Kyle C; Kenealy T; Jackson RT
J Diabetes Complications; 2017 May; 31(5):814-823. PubMed ID: 28319002
[TBL] [Abstract][Full Text] [Related]
19. Skin Autofluorescence and Mortality in Patients on Peritoneal Dialysis.
Mácsai E; Benke A; Kiss I
Medicine (Baltimore); 2015 Nov; 94(45):e1933. PubMed ID: 26559261
[TBL] [Abstract][Full Text] [Related]
20. Mediation analysis of the relationship between type 2 diabetes and cardiovascular events and all-cause mortality: Findings from the SMART cohort.
Sharif S; Groenwold RHH; van der Graaf Y; Berkelmans GFN; Cramer MJ; Visseren FLJ; Westerink J;
Diabetes Obes Metab; 2019 Aug; 21(8):1935-1943. PubMed ID: 31062479
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
